Skip to main content
Clinical Trials/NCT06239662
NCT06239662
Completed
Not Applicable

Therapeutic Education Groups for Childhood Obesity: a Randomized Controlled Trial

Azienda Unità Sanitaria Locale Reggio Emilia0 sites318 target enrollmentSeptember 22, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Childhood Obesity
Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Enrollment
318
Primary Endpoint
BMI z-score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to test the efficacy of an educational therapeutic intervention in treating obesity in a pediatric population.

It aims to verify the differences between the experimental group (group-based program) and the control group (individual program) in respect to the BMI z-score values between baseline measurement (beginning of treatment), final measurement (end of treatment) and 18 months follow-up.

Detailed Description

One of the aim of this clinical trial is to verify that the direct management of the emotional and relational aspects of patients and family plays an important role in maintaining the weight changes achieved in the long term. The potential added value of the present study concerns the better understanding of the role of psychological and emotional aspects in the treatment of childhood obesity and in maintaining results in the long term. The clinical trial aims to recruit 300 obese children randomized in two groups: experimental group and control group.

Registry
clinicaltrials.gov
Start Date
September 22, 2016
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Obesity (\>= 95th percentile);
  • No organic causes of obesity;
  • Sufficient understanding and production of Italian language;
  • Age between 7 and 17 years old;
  • Absence of neuropsychiatric diagnosis;
  • Subscription of the Informed Consent from both parents (or legal guardian).
  • Exclusion Criteria
  • Degree of obesity\< 95th percentile;
  • Organic causes of obesity;
  • Insufficient understanding and production of Italian language;

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

BMI z-score

Time Frame: measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements

BMI z-score variation from baseline to 18 months after the and of treatment

Secondary Outcomes

  • Biohumoral exams from blood sample: Thyroid-stimulating hormone(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • healthy dietary habits(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • unhealthy dietary habits(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Cholesterol(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Psychological questionnaire CBCL (Child Behaviour Checklist)(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Drop-out(measurement at end of treatment i.e approximately 24 months after baseline measurements)
  • Biohumoral exams from blood sample: Uric acid(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Transaminases(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Glycemia(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Insulin(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Glycated hemoglobin(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Biohumoral exams from blood sample: Triglycerides(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Psychological questionnaire TAS-20 (Toronto Alexithymia Scale)(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)
  • Psychological questionnaire PEDSQL (Pediatric Quality of life)(measurement at 18 months after the end of treatment i.e approximately 42 months after baseline measurements)

Similar Trials